| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9343971 | Journal of Cataract & Refractive Surgery | 2005 | 7 Pages |
Abstract
The rabbit model of M chelonae keratitis was successfully developed in our study. A fourth-generation quinolone (gatifloxacin) showed the best performance among the fluoroquinolones tested in our experimental approach. The fourth-generation fluoroquinolone, gatifloxacin, could be effectively used for the treatment of mycobacterial keratitis.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Melvin A. MD, Neda MD, B.J. MD, Paula M. MT, Mehran MD, Jordan M. MD, Anna MD, Kathryn E. PhD, Peter J. MD,